Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26
It keeps your documentation clean, supports medical necessity, and helps improve patient outcomes
acts on reward circuitry Setmelanotide (Imcivree): MC4R agonist for genetic obesity (LEPR, POMC deficiencies) SGLT2 inhibitors (empagliflozin, dapagliflozin): Not FDA-approved for obesity alone but cause weight loss
Women using oral contraceptives should be advised to consider non-oral or additional barrier contraception for 4 weeks after initiation and following each dose increase
A BMI value in the chart is NOT sufficient to assign an obesity code physician documentation of the obesity diagnosis is required per FY2026 ICD-10-CM Official Guidelines, Section I.C.21.c.3
available OTC/Rx Phentermine/topiramate (Qsymia): Sympathomimetic + anticonvulsant combination
2021 Jan;12(1):143-157
US$ 21.12
US$ 22.58
US$ 28.18
